UK Body Urges Action On Licensing Delays As MHRA Unveils Guidance For Established Products

Regulator Aims To Shorten Timeframes For Assessment Of Established Medicines

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.